EKSO (Ekso Bionics Holdings, Inc. Common Stock) Stock Analysis - Analyst Ratings
Ekso Bionics Holdings, Inc. Common Stock (EKSO) is a publicly traded Healthcare sector company. As of May 21, 2026, EKSO trades at $11.80 with a market cap of $42.05M and a P/E ratio of -2.40. EKSO moved -3.56% today. Year to date, EKSO is +151.06%; over the trailing twelve months it is +62.87%. Its 52-week range spans $2.73 to $18.15. Rallies surfaces EKSO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What do analysts rate EKSO?
The average price target is $0.00.
EKSO Key Metrics
Key financial metrics for EKSO
Metric
Value
Price
$11.80
Market Cap
$42.05M
P/E Ratio
-2.40
EPS
$-4.91
Dividend Yield
0.00%
52-Week High
$18.15
52-Week Low
$2.73
Volume
0
Avg Volume
0
Revenue (TTM)
$12.80M
Net Income
$-11.70M
Gross Margin
53.48%
EKSO Analyst Consensus
EKSO analyst coverage data. Average price target: $0.00.
